Clinical Trials on Atopic Conjunctivitis

Total 3898 results

KK Women's and Children's Hospital

Not yet recruiting

Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis

Atopic Dermatitis Eczema
Arcutis Biotherapeutics, Inc.

Completed

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

Atopic Dermatitis Eczema

United States, Canada
Fresh Tracks Therapeutics, Inc.
Syneos Health; Innovaderm Research Inc.

Terminated

A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis Eczema

Canada
AOBiome LLC
Veristat, Inc.

Completed

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States
PurGenesis Technologies Inc.

Completed

Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

Canada
Procter and Gamble

Completed

8-Week Atopic Dermatitis (AD) Treatment Study

Atopic Dermatitis Eczema

United States
Amgen

Completed

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic Dermatitis

Canada, United States, Japan
Momentum Data
Pfizer; Royal College of General Practitioners Research and Surveillance Centre

Unknown

Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK)

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema

United Kingdom
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Guy's and St Thomas' NHS Foundation Trust
King's College London; National Institute for Health Research, United Kingdom

Completed

Role of Anti-IgE in Severe Childhood Eczema (ADAPT)

Child | Atopic Dermatitis | Atopic Eczema

United Kingdom
LEO Pharma

Terminated

Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema

Infected Atopic Dermatitis/Eczema

China
Red Cross War Memorial Childrens Hospital

Unknown

Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.

Severe Atopic Dermatitis

South Africa
AOBiome LLC

Completed

Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.

Atopic Dermatitis Eczema

United States
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Atopic Dermatitis (AD)

United States
Novartis Pharmaceuticals

Completed

Long-term Study of Ciclosporin for Atopic Dermatitis

Severe Atopic Dermatitis
Yuzuncu Yıl University

Completed

Effect of Probiotics in the Atopic Dermatitis

Atopic Dermatitis, Probiotics
Siriraj Hospital

Completed

Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians

Childhood Atopic Dermatitis

Thailand
Bitop AG

Completed

Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents

Seasonal Allergic Rhinitis | Seasonal Allergic Conjunctivitis

Germany
Aldeyra Therapeutics, Inc.

Completed

A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis | Seasonal Allergies

Canada
Federal University of São Paulo

Completed

Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus Keratoconjuntivitis

Adenoviridae Infections | Conjunctivitis, Viral

Brazil
Sun Pharmaceutical Industries Limited

Completed

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Blepharoconjunctivitis
Sanofi

Completed

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China (BALISTAD-CN)

Atopic Dermatitis | Dermatitis Atopic

China
Sanofi

Completed

A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries (AD-impaCT)

Dermatitis Atopic

Saudi Arabia, Kuwait, United Arab Emirates
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Technical University of Munich

Completed

Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage (AMB-WEI-1052-I)

Atopic Dermatitis | Atopic Eczema

Germany
Cytos Biotechnology AG

Completed

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

House Dust Mite Allergy | Perennial Allergic Rhinoconjunctivitis
Cytos Biotechnology AG

Completed

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Perennial Allergy to House Dust Mite and/or Cat

Estonia, Latvia, Lithuania
Gordon Schanzlin New Vision

Completed

Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

Dry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, Evaporative

United States
C.O.C. Farmaceutici S.r.l.

Completed

PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal Abnormalities

Dry Eye | Dry Eye Disease | Kerato Conjunctivitis Sicca

Italy
medac GmbH

Recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Moderate to Severe Atopic Dermatitis

France, Poland, Italy, Czechia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
Guangzhou JOYO Pharma Co., Ltd
Chengdu JOYO pharma Co., Ltd.

Not yet recruiting

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis
Nektar Therapeutics

Recruiting

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis (REZOLVE-AD)

Moderate to Severe Atopic Dermatitis

Spain, Czechia, United States, Australia, Croatia, Bulgaria, Poland, Canada, Germany, Hungary
Kari Nadeau, MD, PhD
University of Chicago; Stanford University; Children's Hospital Medical Center... and other collaborators

Recruiting

Seal, Stopping Eczema and Allergy Study

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Eczema, Infantile

United States, United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies (TREAT NL)

Moderate-to-severe Atopic Eczema

Netherlands
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China

Moderate-to-severe Atopic Dermatitis

China
Wake Forest University Health Sciences

Active, not recruiting

Eucrisa for Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

United States
Shanghai Hengrui Pharmaceutical Co., Ltd.

Enrolling by invitation

A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Moderate-to-severe Atopic Dermatitis

United States, Australia, China, New Zealand
Ichnos Sciences SA
Glenmark Pharmaceuticals S.A.

Completed

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

United States, Canada, Czechia, Germany, Poland
Sterna Biologicals GmbH & Co. KG

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

Mild to Moderate Atopic Dermatitis

Germany
Royal Victoria Infirmary
British Skin Foundation

Completed

Narrowband UVB for Children With Moderate to Severe Atopic Eczema

Moderate to Severe Atopic Eczema

United Kingdom
Bitop AG

Completed

Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
AnaptysBio, Inc.

Recruiting

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Atopic Dermatitis Eczema

Georgia, United States, Australia, Canada, Czechia, New Zealand, Poland
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Imperial College London
JP Moulton Charitable Foundation

Recruiting

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Atopic Dermatitis Eczema

United Kingdom
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
University of California, Irvine
Pfizer

Completed

Characterizing Skin Microbiome Change in Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema

United States
Pfizer
In Expanded Access, treating physicians are the Sponsor

Available

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Severe Uncontrolled Atopic Dermatitis

Clinical Trials on Atopic Conjunctivitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations